BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Slitt AL, Allen K, Morrone J, Aleksunes LM, Chen C, Maher JM, Manautou JE, Cherrington NJ, Klaassen CD. Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. Biochimica et Biophysica Acta (BBA) - Biomembranes 2007;1768:637-47. [DOI: 10.1016/j.bbamem.2006.10.008] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Mennone A, Soroka CJ, Harry KM, Boyer JL. Role of breast cancer resistance protein in the adaptive response to cholestasis. Drug Metab Dispos 2010;38:1673-8. [PMID: 20601550 DOI: 10.1124/dmd.110.034512] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
2 Zhang Y, Csanaky IL, Cheng X, Lehman-McKeeman LD, Klaassen CD. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury. Toxicol Sci 2012;127:451-62. [PMID: 22461449 DOI: 10.1093/toxsci/kfs123] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
3 Woolbright BL, Jaeschke H. Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids. Gene Expr 2019;19:215-28. [PMID: 31253204 DOI: 10.3727/105221619X15614873062730] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
4 Cui YJ, Aleksunes LM, Tanaka Y, Goedken MJ, Klaassen CD. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. Toxicol Sci 2009;110:47-60. [PMID: 19407337 DOI: 10.1093/toxsci/kfp094] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 6.4] [Reference Citation Analysis]
5 Slijepcevic D, Roscam Abbing RLP, Fuchs CD, Haazen LCM, Beuers U, Trauner M, Oude Elferink RPJ, van de Graaf SFJ. Na+ -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice. Hepatology 2018;68:1057-69. [PMID: 29572910 DOI: 10.1002/hep.29888] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
6 Yacovino LL, Aleksunes LM. Endocrine and metabolic regulation of renal drug transporters. J Biochem Mol Toxicol 2012;26:407-21. [PMID: 22933250 DOI: 10.1002/jbt.21435] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
7 Cui JY, Aleksunes LM, Tanaka Y, Fu ZD, Guo Y, Guo GL, Lu H, Zhong XB, Klaassen CD. Bile acids via FXR initiate the expression of major transporters involved in the enterohepatic circulation of bile acids in newborn mice. Am J Physiol Gastrointest Liver Physiol. 2012;302:G979-G996. [PMID: 22268101 DOI: 10.1152/ajpgi.00370.2011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
8 Liu J, Lu H, Lu YF, Lei X, Cui JY, Ellis E, Strom SC, Klaassen CD. Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures. Toxicol Sci 2014;141:538-46. [PMID: 25055961 DOI: 10.1093/toxsci/kfu151] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.8] [Reference Citation Analysis]
9 Gaillard D, Masson D, Garo E, Souidi M, Pais de Barros JP, Schoonjans K, Grober J, Besnard P, Thomas C. Muricholic Acids Promote Resistance to Hypercholesterolemia in Cholesterol-Fed Mice. Int J Mol Sci 2021;22:7163. [PMID: 34281217 DOI: 10.3390/ijms22137163] [Reference Citation Analysis]
10 Scialis RJ, Ghanem CI, Manautou JE. The modulation of transcriptional expression and inhibition of multidrug resistance associated protein 4 (MRP4) by analgesics and their primary metabolites. Curr Res Toxicol 2020;1:34-41. [PMID: 34345835 DOI: 10.1016/j.crtox.2020.04.002] [Reference Citation Analysis]
11 Kawanishi T, Arakawa H, Masuo Y, Nakamichi N, Kato Y. Bile Duct Obstruction Leads to Increased Intestinal Expression of Breast Cancer Resistance Protein With Reduced Gastrointestinal Absorption of Imatinib. Journal of Pharmaceutical Sciences 2019;108:3130-7. [DOI: 10.1016/j.xphs.2019.05.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Robin MJD, Appelman MD, Vos HR, van Es RM, Paton JC, Paton AW, Burgering B, Fickert P, Heijmans J, van de Graaf SFJ. Calnexin Depletion by Endoplasmic Reticulum Stress During Cholestasis Inhibits the Na+-Taurocholate Cotransporting Polypeptide. Hepatol Commun 2018;2:1550-66. [PMID: 30556041 DOI: 10.1002/hep4.1262] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
13 Baek A, Kim H, Yang J, Choi G, Kim M, Cho AE, Kim Y, Kim S, Sung B, Woo Yang B, Seo H, Lee G, Ryeom H, Jung H, Lee T, Chang Y. High-performance hepatobiliary dysprosium contrast agent for ultra-high-field magnetic resonance imaging. Journal of Industrial and Engineering Chemistry 2020;85:297-307. [DOI: 10.1016/j.jiec.2020.02.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Slijepcevic D, Roscam Abbing RLP, Katafuchi T, Blank A, Donkers JM, van Hoppe S, de Waart DR, Tolenaars D, van der Meer JHM, Wildenberg M, Beuers U, Oude Elferink RPJ, Schinkel AH, van de Graaf SFJ. Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice. Hepatology 2017;66:1631-43. [PMID: 28498614 DOI: 10.1002/hep.29251] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 12.0] [Reference Citation Analysis]
15 Song P, Rockwell CE, Cui JY, Klaassen CD. Individual bile acids have differential effects on bile acid signaling in mice. Toxicol Appl Pharmacol. 2015;283:57-64. [PMID: 25582706 DOI: 10.1016/j.taap.2014.12.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
16 Cressman AM, Petrovic V, Piquette-miller M. Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response. Expert Review of Clinical Pharmacology 2014;5:69-89. [DOI: 10.1586/ecp.11.66] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
17 Miszczuk GS, Banales JM, Zucchetti AE, Pisani GB, Boaglio AC, Saez E, Medina JF, Roma MG, Crocenzi FA. Adaptive downregulation of Cl-/HCO3- exchange activity in rat hepatocytes under experimental obstructive cholestasis. PLoS One 2019;14:e0212215. [PMID: 30789925 DOI: 10.1371/journal.pone.0212215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
18 Csanaky IL, Aleksunes LM, Tanaka Y, Klaassen CD. Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. Am J Physiol Gastrointest Liver Physiol. 2009;297:G419-G433. [PMID: 19497955 DOI: 10.1152/ajpgi.90728.2008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
19 Xu Q, Wang C, Liu Q, Meng Q, Sun H, Peng J, Sun P, Huo X, Liu K. Decreased liver distribution of entecavir is related to down-regulation of Oat2/Oct1 and up-regulation of Mrp1/2/3/5 in rat liver fibrosis. European Journal of Pharmaceutical Sciences 2015;71:73-9. [DOI: 10.1016/j.ejps.2015.02.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
20 Claudel T, Zollner G, Wagner M, Trauner M. Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011;1812:867-78. [DOI: 10.1016/j.bbadis.2010.12.021] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
21 zhang A, Jia Y, Xu Q, Wang C, Liu Q, Meng Q, Peng J, Sun H, Sun P, Huo X, Liu K. Dioscin protects against ANIT–induced cholestasis via regulating Oatps, Mrp2 and Bsep expression in rats. Toxicology and Applied Pharmacology 2016;305:127-35. [DOI: 10.1016/j.taap.2016.06.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
22 Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev. 2010;62:1-96. [PMID: 20103563 DOI: 10.1124/pr.109.002014] [Cited by in Crossref: 532] [Cited by in F6Publishing: 479] [Article Influence: 44.3] [Reference Citation Analysis]
23 Zhu L, Wang L, Cao F, Liu P, Bao H, Yan Y, Dong X, Wang D, Wang Z, Gong P. Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1α. J Hepatobiliary Pancreat Sci 2018;25:195-205. [DOI: 10.1002/jhbp.537] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
24 Hanley J, Dhar DK, Mazzacuva F, Fiadeiro R, Burden JJ, Lyne AM, Smith H, Straatman-Iwanowska A, Banushi B, Virasami A, Mills K, Lemaigre FP, Knisely AS, Howe S, Sebire N, Waddington SN, Paulusma CC, Clayton P, Gissen P. Vps33b is crucial for structural and functional hepatocyte polarity. J Hepatol 2017;66:1001-11. [PMID: 28082148 DOI: 10.1016/j.jhep.2017.01.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
25 Woolbright BL. Inflammation: Cause or consequence of chronic cholestatic liver injury. Food Chem Toxicol. 2020;137:111133. [PMID: 31972189 DOI: 10.1016/j.fct.2020.111133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Canet MJ, Cherrington NJ. Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis. Expert Opin Drug Metab Toxicol. 2014;10:1209-1219. [PMID: 24989624 DOI: 10.1517/17425255.2014.936378] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
27 Lickteig AJ, Cheng X, Augustine LM, Klaassen CD, Cherrington NJ. Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice. Life Sci 2008;83:59-64. [PMID: 18573474 DOI: 10.1016/j.lfs.2008.05.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
28 Miura T, Tachikawa M, Ohtsuka H, Fukase K, Nakayama S, Sakata N, Motoi F, Naitoh T, Katayose Y, Uchida Y, Ohtsuki S, Terasaki T, Unno M. Application of Quantitative Targeted Absolute Proteomics to Profile Protein Expression Changes of Hepatic Transporters and Metabolizing Enzymes During Cholic Acid-Promoted Liver Regeneration. Journal of Pharmaceutical Sciences 2017;106:2499-508. [DOI: 10.1016/j.xphs.2017.02.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zoufal V, Mairinger S, Krohn M, Wanek T, Filip T, Sauberer M, Stanek J, Traxl A, Schuetz JD, Kuntner C, Pahnke J, Langer O. Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[11C]Methylpurine in Mice. Mol Imaging Biol 2019;21:306-16. [PMID: 29942989 DOI: 10.1007/s11307-018-1230-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
30 Kim JH, Wang M, Lee J, Park HJ, Han C, Hong HS, Kim JS, An GH, Park K, Park HK, Zhu SF, Sun XB, Kim JH, Woo DH. Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes. Cell Biol Toxicol 2018;34:51-64. [PMID: 28382404 DOI: 10.1007/s10565-017-9392-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
31 Roma MG, Crocenzi FA, Sánchez Pozzi EA. Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects. Clin Sci (Lond) 2008;114:567-88. [PMID: 18377365 DOI: 10.1042/CS20070227] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
32 Aleksandrova MI, Kushnareva NS, Smirnova OV. Manifestation of multidrug resistance protein 3 (MRP3) in liver and kidney cells in cholestasis: effects of hyperprolactinemia. Bull Exp Biol Med 2013;154:508-11. [PMID: 23486593 DOI: 10.1007/s10517-013-1989-4] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
33 Woolbright BL, Jaeschke H. Therapeutic targets for cholestatic liver injury. Expert Opin Ther Targets 2016;20:463-75. [PMID: 26479335 DOI: 10.1517/14728222.2016.1103735] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
34 Gyamfi MA, Tanaka Y, He L, Klaassen CD, Wan YJ. Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice. Toxicol Appl Pharmacol 2009;234:166-78. [PMID: 18952117 DOI: 10.1016/j.taap.2008.09.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
35 Zhang Y, Csanaky IL, Selwyn FP, Lehman-McKeeman LD, Klaassen CD. Organic anion-transporting polypeptide 1a4 (Oatp1a4) is important for secondary bile acid metabolism. Biochem Pharmacol 2013;86:437-45. [PMID: 23747753 DOI: 10.1016/j.bcp.2013.05.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
36 Wu T, Zhang Q, Li J, Chen H, Wu J, Song H. Up-regulation of BSEP and MRP2 by Calculus Bovis administration in 17α-ethynylestradiol-induced cholestasis: Involvement of PI3K/Akt signaling pathway. Journal of Ethnopharmacology 2016;190:22-32. [DOI: 10.1016/j.jep.2016.05.056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
37 Cheng X, Buckley D, Klaassen CD. Regulation of hepatic bile acid transporters Ntcp and Bsep expression. Biochem Pharmacol 2007;74:1665-76. [PMID: 17897632 DOI: 10.1016/j.bcp.2007.08.014] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
38 Klein DM, Wright SH, Cherrington NJ. Xenobiotic transporter expression along the male genital tract. Reprod Toxicol 2014;47:1-8. [PMID: 24814985 DOI: 10.1016/j.reprotox.2014.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
39 Bright AS, Herrera-Garcia G, Moscovitz JE, You D, Guo GL, Aleksunes LM. Regulation of Drug Disposition Gene Expression in Pregnant Mice with Car Receptor Activation. Nucl Receptor Res 2016;3:101193. [PMID: 27818994 DOI: 10.11131/2016/101193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
40 Canet MJ, Hardwick RN, Lake AD, Dzierlenga AL, Clarke JD, Goedken MJ, Cherrington NJ. Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis. Drug Metab Dispos 2015;43:266-72. [PMID: 25488932 DOI: 10.1124/dmd.114.060574] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
41 Sasaki K, Tachikawa M, Uchida Y, Hirano S, Kadowaki F, Watanabe M, Ohtsuki S, Terasaki T. ATP-Binding Cassette Transporter A Subfamily 8 Is a Sinusoidal Efflux Transporter for Cholesterol and Taurocholate in Mouse and Human Liver. Mol Pharmaceutics 2018;15:343-55. [DOI: 10.1021/acs.molpharmaceut.7b00679] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
42 Chen H, Huang X, Min J, Li W, Zhang R, Zhao W, Liu C, Yi L, Mi S, Wang N, Wang Q, Zhu C. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2. Journal of Ethnopharmacology 2016;179:197-207. [DOI: 10.1016/j.jep.2015.12.033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
43 Gu X, Manautou JE. Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metab Rev 2010;42:482-538. [PMID: 20233023 DOI: 10.3109/03602531003654915] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
44 Roda A, Aldini R, Camborata C, Spinozzi S, Franco P, Cont M, D'Errico A, Vasuri F, Degiovanni A, Maroni L, Adorini L. Metabolic Profile of Obeticholic Acid and Endogenous Bile Acids in Rats with Decompensated Liver Cirrhosis. Clin Transl Sci 2017;10:292-301. [PMID: 28411380 DOI: 10.1111/cts.12468] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
45 Stieger B. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol. 2011;205-259. [PMID: 21103971 DOI: 10.1007/978-3-642-14541-4_5] [Cited by in Crossref: 170] [Cited by in F6Publishing: 159] [Article Influence: 15.5] [Reference Citation Analysis]
46 Stoeber R. Highlight report: Imaging of bile ducts and the bile canalicular network. EXCLI J 2019;18:477-8. [PMID: 31423126 DOI: 10.17179/excli2019-1548] [Reference Citation Analysis]
47 Torres AM, Dnyanmote AV, Granados JC, Nigam SK. Renal and non-renal response of ABC and SLC transporters in chronic kidney disease. Expert Opin Drug Metab Toxicol 2021;17:515-42. [PMID: 33749483 DOI: 10.1080/17425255.2021.1899159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Wang T, Zhou ZX, Sun LX, Li X, Xu ZM, Chen M, Zhao GL, Jiang ZZ, Zhang LY. Resveratrol effectively attenuates alpha-naphthylisothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms. Acta Pharmacologica Sinica. 2014;35:1527-1536. [PMID: 25418378 DOI: 10.1038/aps.2014.119] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
49 Jansen PL, Ghallab A, Vartak N, Reif R, Schaap FG, Hampe J, Hengstler JG. The ascending pathophysiology of cholestatic liver disease. Hepatology 2016;65:722-38. [DOI: 10.1002/hep.28965] [Cited by in Crossref: 122] [Cited by in F6Publishing: 119] [Article Influence: 24.4] [Reference Citation Analysis]
50 Aleksunes LM, Yeager RL, Klaassen CD. Application of multivariate statistical procedures to identify transcription factors that correlate with MRP2, 3, and 4 mRNA in adult human livers. Xenobiotica 2009;39:514-22. [PMID: 19480556 DOI: 10.1080/00498250902952514] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
51 Ghanem CI, Manautou JE. Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics. Curr Med Chem 2019;26:1185-223. [PMID: 29473496 DOI: 10.2174/0929867325666180221142315] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
52 Giroux P, Kyle PB, Tan C, Edwards JD, Nowicki MJ, Liu H. Evaluating the regulation of transporter proteins and P-glycoprotein in rats with cholestasis and its implication for digoxin clearance. World J Gastrointest Pathophysiol 2022; 13(3): 73-84 [DOI: 10.4291/wjgp.v13.i3.73] [Reference Citation Analysis]
53 Zou W, Shi B, Zeng T, Zhang Y, Huang B, Ouyang B, Cai Z, Liu M. Drug Transporters in the Kidney: Perspectives on Species Differences, Disease Status, and Molecular Docking. Front Pharmacol 2021;12:746208. [PMID: 34912216 DOI: 10.3389/fphar.2021.746208] [Reference Citation Analysis]